Wound Management News

During the course of 6 months, once-monthly triple antibiotic treatment helped improve, but did not clear, granuloma annulare, according to study findings.

Measles infection was shown to have a substantial short-term impact on health-related quality of life at both the individual patient level as well as for overall disease burden, according to study findings.

WASHINGTON, D.C. — Among patients with community-acquired Staphylococcus aureus who presented to the ED with closed skin abscesses, CC8-300 was the most common MRSA colonizing strain, according to data presented at ICAAC 2014.

Solace International has voluntarily recalled all lots of Dermatend Original and Dermatend Ultra, in all sizes and dosages, to the distributor/wholesaler level, according to a press release from the U.S. Food and Drug Administration.

Researchers have reported an association between skin trauma and the development of morphea lesions at the site of antecedent injury, suggesting that that elective procedures and excessive skin trauma or friction should potentially be avoided in these patients.

Ionic liquids may be an effective resource in combating bacterial skin infections protected by biofilm, according to recent study data published in the Proceedings of the National Academy of Science.

Saliva could be a source of transmission for varicella zoster virus in ambulatory adult patients with localized herpes zoster, according to data from a study poster presented at the American Academy of Dermatology Summer Meeting.

Cubist Pharmaceuticals voluntarily recalled nine lots of daptomycin for injection because of foreign particulate matter found in reconstituted vials, according to a press release from the manufacturer.

The FDA approved the antibacterial agent oritavancin, making it the third antibiotic approved in 2014 to treat skin infections, according to an agency press release.

The U.S. Food and Drug Administration announced that some health care providers have used an intranasal splint from Enhancement Medical as a dermal filler — an indication for which the product has not been FDA-approved.